ImmuCell Corporation Shareholders' Equity
ImmuCell Corporation (ICCC) had Shareholders' Equity of $31.37 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $31.37M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $29.14M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $27.06M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $29.80M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $31.37M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $29.14M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $27.06M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $29.80M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $29.87M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $28.99M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $27.52M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $26.41M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $23.46M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $24.64M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $24.99M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $26.01M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $26.86M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $28.16M 10-Q · filed 2024-08-13 | |
| 2022-12-31 | $30.38M 10-K · filed 2025-03-28 | |
| 2022-09-30 | $31.98M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $32.55M 10-Q · filed 2023-11-13 | $32.77M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $33.15M 10-Q · filed 2023-08-10 | $33.37M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $32.58M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $32.46M 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $32.27M 10-Q/A · filed 2022-11-21 | |
| 2021-03-31 | $27.87M 10-Q/A · filed 2022-11-21 | |
| 2020-12-31 | $28.27M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $28.02M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $28.28M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $28.99M 10-Q · filed 2021-08-12 | $28.99M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $28.99M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $29.19M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $29.65M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $30.25M 10-Q · filed 2020-08-12 | $30.25M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $21.74M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $22.67M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $22.81M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $23.49M 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $23.59M 10-K · filed 2020-03-27 | |
| 2017-09-30 | $20.95M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $20.20M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $20.37M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $19.72M 10-K · filed 2019-03-22 | |
| 2016-09-30 | $16.41M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $16.31M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $16.32M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $10.61M 10-K · filed 2018-03-29 | |
| 2015-09-30 | $10.30M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $9.90M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $9.74M 10-Q · filed 2016-05-11 | |
| 2014-12-31 | $9.26M 10-K · filed 2017-03-30 | |
| 2014-09-30 | $9.12M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $9.10M 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $9.39M 10-Q · filed 2015-05-12 | |
| 2013-12-31 | $9.40M 10-K · filed 2016-03-25 | |
| 2013-09-30 | $9.51M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $9.45M 10-Q · filed 2014-11-12 | |
| 2013-03-31 | $9.41M 10-Q · filed 2014-05-14 | |
| 2012-12-31 | $9.19M 10-K · filed 2016-03-25 | |
| 2012-09-30 | $9.20M 10-Q · filed 2013-11-13 | |
| 2012-06-30 | $9.26M 10-Q · filed 2013-08-13 | |
| 2012-03-31 | $9.25M 10-Q · filed 2013-05-14 | |
| 2011-12-31 | $9.02M 10-K · filed 2015-03-26 | |
| 2011-09-30 | $8.99M 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $9.04M 10-Q/A · filed 2012-09-07 | |
| 2011-03-31 | $9.27M 10-Q · filed 2012-05-14 | |
| 2010-12-31 | $9.28M 10-K · filed 2014-03-26 | |
| 2010-09-30 | $9.35M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $9.58M 10-Q · filed 2011-08-15 | |
| 2009-12-31 | $9.62M 10-K · filed 2013-03-28 | |
| 2008-12-31 | $9.64M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |